Your session is about to expire
← Back to Search
Pulse-Based Diet for Healthy Lifestyle (PRODMED1 Trial)
N/A
Waitlist Available
Led By Moul Dey, Ph.D.
Research Sponsored by South Dakota State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a plant-based diet rich in pulses to help older adults maintain muscle mass and improve health. The diet is low in certain compounds that can cause health issues, aiming to improve blood sugar levels, body composition, and overall health by supporting a healthy gut.
Who is the study for?
This trial is for people aged 60 or older, weighing at least 110 lbs, with normal HbA1C levels indicating generally good health. Participants should be currently following a meat-based diet without special dietary requirements and willing to eat on-site meals and provide samples. All races and sexes are welcome.
What is being tested?
The study tests the effects of a pulse-protein-based diet compared to a traditional meat-based diet on various health markers in older adults. It aims to see if this plant-based diet can improve long-term health outcomes by analyzing around 500 different biomarkers.
What are the potential side effects?
Since the intervention involves dietary changes, side effects may include digestive adjustments such as bloating or gas when introducing pulses into the diet. However, no specific side effects are listed as it's based on healthy lifestyle changes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Concentration of TMAO in blood
Fasting blood glucose concentration in blood
Frequency of sit/stand using Chair rise test
Secondary study objectives
Balance assessment using balance and gait score
Blood pressure in mm Hg
Body weight in kilograms
+16 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Pulse basedExperimental Treatment1 Intervention
Pulse-protein-based dietary intervention
Group II: Meat basedExperimental Treatment1 Intervention
Animal protein-based dietary intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
A pulse-protein-based diet, which is naturally low in methionine (Met) and trimethylamine N-oxide (TMAO) production, offers several mechanisms of action that contribute to a healthy lifestyle. Pulses are rich in micronutrients and dietary fibers, which help stimulate the gut microbiome, leading to beneficial metabolic and anti-inflammatory adaptations.
This diet can improve glycemic control, enhance body composition, and increase immunometabolic flexibility, thereby reducing the risk of chronic diseases and promoting longevity. These mechanisms are particularly important for patients aiming to maintain a healthy lifestyle, as they address both nutritional needs and long-term health outcomes.
Increased protein intake derived from leucine-enriched protein enhances the integrated myofibrillar protein synthetic response to short-term resistance training in untrained men and women: a 4-day randomized controlled trial.High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.Improved recovery from skeletal muscle damage is largely unexplained by myofibrillar protein synthesis or inflammatory and regenerative gene expression pathways.
Increased protein intake derived from leucine-enriched protein enhances the integrated myofibrillar protein synthetic response to short-term resistance training in untrained men and women: a 4-day randomized controlled trial.High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.Improved recovery from skeletal muscle damage is largely unexplained by myofibrillar protein synthesis or inflammatory and regenerative gene expression pathways.
Find a Location
Who is running the clinical trial?
South Dakota State UniversityLead Sponsor
20 Previous Clinical Trials
10,030 Total Patients Enrolled
Moul Dey, Ph.D.Principal InvestigatorSouth Dakota State University
1 Previous Clinical Trials
59 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of cancer, diabetes, heart, liver, or kidney diseases.I have not had major stomach or intestine problems in the last 3 months.I have had a heart attack or stroke in the past.I am 60 years or older and in good health.My kidney function is not normal.I mainly eat meat, have no special diet needs, and agree to follow the study's eating and testing plan.I cannot attend in-person visits for meals or tests.I use medications, probiotics, long-term antibiotics, or have used tobacco, drugs, or alcohol.My HbA1C levels are normal and I weigh at least 110 pounds.
Research Study Groups:
This trial has the following groups:- Group 1: Meat based
- Group 2: Pulse based
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Healthy Lifestyle Patient Testimony for trial: Trial Name: NCT05577858 — N/A